Ledger.Open graph →
SEC Form D · filed March 10, 2022

Genomenon, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

David Gregorka · ANN ARBOR, MIDirectorMark Kiel · ANN ARBOR, MIExec · DirectorMichael Klein · ANN ARBOR, MIExec · DirectorPatricia Glaza · ANN ARBOR, MIDirectorBlazena N. Grossman · Luxembourg, LuxembourgDirectorDaniel Wallerstorfer · Wilmington, DEExec · DirectorAneta N. Bondar · Luxembourg, LuxembourgDirectorRachel Sanders · Wilmington, DEExec · DirectorMichael Gross · Halifax, Nova Scotia, CanadaDirectorGil Zimmermann · Newton, MAExec · DirectorKarla J. Bullard · CHICAGO, ILExec · DirectorElizabeth Q. Betten · CHICAGO, ILDirectorPaul J. Finnegan · CHICAGO, ILDirectorMichael Gross · Ann Arbor, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗